Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Pulse Data updates Year in cancer Taxonomy Countries Compare Trial intelligence Trial map Drug pipeline Sources Methodology About Trust & policies Data downloads Developers (API)

Loading cancer entity…

CancerIndex

CancerIndex is a research and information platform. It is not a physician, does not diagnose, and does not recommend treatment. Population statistics do not predict individual outcomes.

Every number links to its source and retrieval date. Derived metrics carry a formula version. AI-generated synthesis is not enabled in this phase; all content is database-grounded.

About Trust & policies Data explorer Data downloads Pulse Data update log Developers (API)Sources Methodology Taxonomy Countries Compare Contact · contact@spboucher.ai Status

© 2026 CancerIndex · built and maintained by Simon-Pierre Boucher · contact contact@spboucher.ai · hosted on MacLustr (www.maclustr.io). Source data remains under the license of each provider — see /sources.

Precursor Lymphoid Neoplasm — Trials · CancerIndex

Cancers
Neoplasm
Neoplasm by Special Category
Malignant Neoplasm
Precursor Lymphoid Neoplasm

Cancer Family

Precursor Lymphoid Neoplasm

CI-CAN-00000327Explore in graph →

Hematologic567 active trials12 approved drugs212 evidence items

NCIt: C7055

Overview
Statistics
Survival
Genomics7
Variants & evidence212
Drugs31
Trials2154
Research
Rankings
Sources & provenance

Clinical trials

Registered studies

2,154 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 567
Recruiting: 344
Ph III recruiting: 27
Growth YoY: −11.9%
Industry share: 13%
Top sponsor: City of Hope Medical Center
Termination share: 33.1%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (286)

StatusAll Active (any)Completed 868 Recruiting 403 Unknown 309 Terminated 215 Active Not Recruiting 163 Not Yet Recruiting 83 Withdrawn 75 Suspended 13 Enrolling By Invitation 12 No Longer Available 7 Available 5 Approved For Marketing 1

PhaseAll Early Phase 1 62 N/A 318 Phase 1 722 Phase 2 778 Phase 3 145 Phase 4 57

No study matches these filters